Eliminating viral hepatitis as a public health threat by 2030 is a target set under the UN Sustainable Development Goal on Health (1). To mark World Hepatitis Day, we have released today an update of our interactive elimination barometer, a tool designed to help countries monitor their progress towards eliminating viral hepatitis among people who inject drugs.
Chronic viral hepatitis can result in serious liver diseases, such as liver cirrhosis and cancer. Hepatitis C virus (HCV) infection is associated with a high burden of disease among people who inject drugs (PWID), the virus being…
Čtěte více
Did you know that something as simple as a sterile syringe can save lives? The vital role of harm reduction equipment in reducing the health risks associated with high-risk drug use, is explored today in a new EUDA miniguide. The resource forms part of the agency’s Health and social responses to drug problems: a European guide and is the second in a bundle of miniguides dedicated to drug-related interventions (1).
Harm reduction equipment is designed to minimise a range of drug-related risks, by allowing the hygienic preparation of illicit drugs and reducing the risks of their administration…
Čtěte více
Exactly one year ago today, we became the European Union Drugs Agency (EUDA) and embarked on our new mission to strengthen EU preparedness on drugs. Building on the work of the EMCDDA, and with a more proactive mandate, we set off to support the EU and its Member States in addressing emerging drug issues in an ever-changing world. Our work contributes to making Europe's streets safer and…
Čtěte více
